Skip to main content
TDAC logo

TDAC · Translational Development Acquisition Corp.

$10.85 +0.01 (+0.05%) At close · Aug 5
Market Cap
$237.59M
Shares
21.91M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.85 Open$10.84 Day$10.84–10.89 52W$10.32–10.95 Avg vol 30d27K Short int5K · 0.0% float · 1.0d Short vol69% DataFeb 2025–Aug 2026 Filing10-Q · May 15

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 15, 2026

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very Low
Market backdrop VIX 15.8 · calm Equity put/call 0.46
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +3%
above
Price vs 50-day avg +1%
above
RSI (14) 76
overbought
MACD trend Positive
52-week position 83%
mid-range
Momentum
relative strength
Strong
1-month return +1%
trailing
6-month return +3%
trailing
YTD return +3%
this year
Relative strength −8%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $11 › 200d $11 — 50d above 200d
Institutional flow Distributing
4 of 48 funds reported for Jun 30 · net -106.2K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of float · ▲ +64.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
48 holders — near 1-yr high, broad support
Squeeze score 40
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very Low
Volatility 2%
annualized · 1-yr
Max drawdown −1%
past year
ATR 0.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 2 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+3% Bullish
Price vs 50-day avg
+1% Bullish
RSI (14)
76 Bearish
MACD trend
Positive Bullish
52-week position
83% Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $11 › 200d $11 — 50d above 200d
Institutional flow Distributing
4 of 48 funds reported for Jun 30 · net -106.2K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of float · ▲ +64.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
48 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $10 Now $11 · 83% 52-wk high $11
vs 200-day avg +3% vs 50-day avg +1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TDAC
Translational Development Acquisition Corp.
this stock
$237.59M +3.4% 0.0%
CLUS
Cluster Group Holdings Ltd Co
$8.00B +0.0% 100.2
NIMU
Non Invasive Monitoring Systems Inc /Fl/
$1.63B +2943.5% -73.9% 0.0%
CCXI
Churchill Capital Corp XI
$889.07M 1.8%
DMII
Drugs Made In America Acquisition II Corp.
$644.01M +2.1% 0.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
47
% held
73.6%
Reported
4 of 48
Top holder
Magnetar Financial LLC
Held Float
View
Held by Funds
Fund positions
5
View
Short & Settlement
Short Interest Rising
Shares short
4.9K
Days to cover
1.0d
Change
+1.9K sh
View
Short Volume
Short vol %
69%
As of
Aug 5, 2026
Short Total
View
Fails to Deliver
FTD shares
72
Value
$770
As of
Jul 14, 2026
View
Off-Exchange
Off-exchange %
43.9%
Week of
Jun 29, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$6.4M
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 27, 2026
This year
11
View

Performance

5D 20D 120D MTD YTD
TDAC +0.2% +1.4% +2.9% +0.1% +3.4%
SPY +5.5% +3.3% +11.3% +3.1% +12.9%
vs SPY -5.3% -1.9% -8.3% -2.9% -9.5%
Key facts CIK 1926599 CUSIP G9008W105 13F (30d) 3 filings 3 filers Visit website Investor relations